Latest Patent And Technology News

Volt Resources Limited reports strong quarterly progress in graphite production and downstream development, securing new orders and partnerships while advancing US refinery plans and implementing cost-saving measures.

Way2VAT Ltd reported a robust 54% increase in Q1 FY25 revenue to A$1.05 million, driven by new client onboarding and higher VAT claim volumes, alongside strategic cost reductions and fresh credit facilities.

Environmental Clean Technologies Limited (ECT) has raised $750,000 through a two-tranche placement to fund its innovative COLDry Fertiliser Project and pursue strategic acquisitions, alongside key board changes.

Calix Limited and Pilbara Minerals have recommenced construction on their Mid-Stream Demonstration Plant following a $15 million grant from the Western Australian Government, aiming for completion by December 2025.

Artrya has secured a pivotal three-year commercial contract with Sonic Healthcare Australia to deploy its AI-driven Salix Coronary Anatomy platform across over 125 radiology centres, marking a significant step in commercialising its coronary artery disease diagnostic technology.

Micro-X Ltd has announced a $6 million capital raising alongside a $2.4 million strategic investment from Billion Prima, underpinning its pivot towards medical imaging and cashflow stability.

First Graphene Limited reports a robust December quarter with new patents, expanded distribution networks, and advancing commercial trials, positioning the company on a path to cash breakeven.

Elevate Uranium Ltd has raised $25 million to advance its proprietary U-pgrade™ beneficiation process and accelerate exploration across its Namibian and Australian uranium projects. The company is poised to operationalize a demonstration plant in Namibia by late 2025 while expanding its resource base through extensive drilling campaigns.

AML3D Limited has reported a strong December quarter marked by significant defense contract completions, a $30 million capital raise, and strategic expansion into the US and European markets. The company is poised for accelerated growth, underpinned by a major US Navy funding boost and new sector entries.

4DMedical reports a remarkable 202% increase in Q2 FY2025 operating revenue, driven by rapid site expansion and key collaborations with leading healthcare providers and the U.S. Department of Defense.

First Graphene has secured key patents for its Kainos Technology in Australia and Korea, positioning itself at the forefront of producing graphite, graphene, and hydrogen from petroleum waste. This milestone aligns with growing global demand for critical minerals essential to the energy transition.

4DMedical has signed a landmark commercial agreement with Qscan Radiology Clinics, marking its first Australian contract to integrate both Pulmonary Function and Pulmonary Structure imaging products.